The development was carried out by experts from MI Platov University in Novocherkassk and the ND Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences.
N-heterocyclic carbenes, these catalysts created using organic molecules, play an important role in chemical reactions and are considered promising for many fields, including pharmaceuticals.
Viktor Chernyshev argues that new catalysts will increase the stability of drug synthesis processes and reduce the required raw materials and the amount of waste. In the future, this could lead to a reduction in catalyst dosage of up to 10 times.
Catalysts will also facilitate the process of purifying drugs from unwanted components and accelerate the production of medicinal drugs. Scientists have already tested new catalysts to produce drugs for cancer and arrhythmic diseases.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
